Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness

Philip D. Harvey, Tim B. Bigdeli, Ayman H. Fanous, Yuli Li, Nallakkandi Rajeevan, Frederick Sayward, Krishnan Radhakrishnan, Grant Huang, Mihaela Aslan

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Background: Personalization of psychiatric treatment includes treatment of symptoms, cognition and functional deficits, suicide, and medical co-morbidities. VA Collaborative Study 572 examined a large sample of male and female veterans with schizophrenia (n = 3,942) and with bipolar disorder (n = 5,414) with phenotyping and genomic analyses. We present the results to date and future directions. Methods: All veterans received a structured diagnostic interview and assessments of suicidal ideation and behavior, PTSD, and health. Veterans with schizophrenia were assessed for negative symptoms and lifetime depression. All were assessed with a cognitive and functional capacity assessment. Data for genome wide association studies were collected. Controls came from the VA Million Veteran Program. Results: Suicidal ideation or behavior was present in 66%. Cognitive and functional deficits were consistent with previous studies. 40% of the veterans with schizophrenia had a lifetime major depressive episode and PTSD was present in over 30%. Polygenic risk score (PRS) analyses indicated that cognitive and functional deficits overlapped with PRS for cognition, education, and intelligence in the general population and PRS for suicidal ideation and behavior correlated with previous PRS for depression and suicidal ideation and behavior, as did the PRS for PTSD. Discussion: Results to date provide directions for personalization of treatment in SMI, veterans with SMI, and veterans in general. The results of the genomic analyses suggest that cognitive deficits in SMI may be associated with general population features. Upcoming genomic analyses will reexamine the issues above, as well as genomic factors associated with smoking, substance abuse, negative symptoms, and treatment response.

Original languageEnglish (US)
Article number100078
JournalPersonalized Medicine in Psychiatry
StatePublished - Jul 1 2021
Externally publishedYes


  • Bipolar Disorder
  • Cognition
  • Disability
  • Gemonics
  • Genomincs
  • Schizophrenia
  • Veterans

ASJC Scopus subject areas

  • Clinical Psychology
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Cooperative studies Program (CSP) #572: A study of serious mental illness in veterans as a pathway to personalized medicine in schizophrenia and bipolar illness'. Together they form a unique fingerprint.

Cite this